SHILPA PATIL

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Acvr1bloss promotes formation of precancerous lesions from acinar and ductal cells of origin
  2023 DOI: 10.1101/2023.06.08.544226
  +Save
• Data from EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6
  2023 DOI: 10.1158/0008-5472.c.6512616
  +Save
• NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming.
  Cellular and molecular gastroenterology and hepatology 2023 DOI: 10.1016/j.jcmgh.2023.01.015
  +Save
• TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
  Cancers 2022 DOI: 10.3390/cancers14143451
  +Save
• Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
  2022 DOI: 10.1101/2022.05.06.490845
  +Save
• Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes
  Visceral Medicine 2022 DOI: 10.1159/000520946
  +Save
• Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer
  Cells 2021 DOI: 10.3390/cells10123463
  +Save
• HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells
  Cancers 2021 DOI: 10.3390/cancers13246163
  +Save
• EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6
  Cancer Research 2020 DOI: 10.1158/0008-5472.CAN-20-0672
  +Save
• Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer.
  Cells 2019 DOI: 10.3390/cells8060563
  +Save